Carbidopum (Carbidopa) API Manufacturers

compare suppliers & get competitive offers

Average price per kilo
Number of transactions
Number of searches

Filters

Reset

Selected filters:

Type
Production region
Qualifications
Country of origin

Produced in:

China

Established in: 1987

MOQ: 1 kg

Employees: 50+

Passed ISO9001:2015 and SGS audit

Provide one-stop CDMO service from R&D to production

Specialized in APIs & Pharmaceutical Intermediates for 37 years

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • GMP

  • CoA

  • ISO9001

  • MSDS

  • CEP

Produced in:

India

Established in: 1968

MOQ: 5 g

Employees: 50+

Warehouse stock of nearly all APIs

GMP, GDP and ISO certified

Customisable (small-sized) packages

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • ISO9001

  • CoA

  • MSDS

Produced in:

Unknown

Established in: 1963

MOQ: -

Employees: 800+

World’s 1st exclusive API distributor

Portfolio of 600+ APIs

>250 clients in Europe

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • CoA

  • MSDS

Producer

Produced in:

Unknown

Established in: 1944

MOQ: -

Employees: 4,000

14 international API plant sites

Portfolio of 350+ APIs

Teva is among the world’s largest generic drug/API manufacturers

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • CEP

  • DMF

  • GMP

  • FDA

  • coa

Located in:

China

Produced in:

China

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • CEP

  • WC

  • DMF

  • FDA

  • coa

Located in:

China

Produced in:

China

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • CEP

  • coa

  • DMF

  • WC

Located in:

India

Producer

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • WC

  • GMP

  • FDA

  • coa

Located in:

China

Produced in:

China

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • FDA

  • coa

  • CEP

  • DMF

  • JDMF

  • WC

Located in:

India

Producer

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • JDMF

  • coa

  • ISO

  • ISO 9001

  • GMP

  • CEP

  • WC

  • FDA

  • KDMF

Located in:

Italy

Producer

Produced in:

Italy

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • CoA

Located in:

Finland

Producer

Produced in:

Finland

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • coa

  • DMF

  • CEP

  • GMP

  • GDP

  • BSE/TSE

  • MSDS

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Carbidopa API 28860-95-9?

Description:
Here you will find a list of producers, manufacturers and distributors of Carbidopa. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Carbidopa 
Synonyms:
Carbidopum , L-methyldopahydrazine  
Cas Number:
28860-95-9 
DrugBank number:
DB00190 
Unique Ingredient Identifier:
KR87B45RGH

About Carbidopa

What makes Carbidopa unique? Carbidopa presents a chemical denomination of N-amino-alpha-methyl-3-hydroxy-L-tyrosine monohydrate. It potently inhibits aromatic amino acid decarboxylase (DDC) and due to its chemical properties, it does not cross the blood-brain barrier. Due to its activity, carbidopa is always administered concomitantly with levodopa. An individual formulation containing solely carbidopa was generated to treat nausea in patients where the combination therapy levodopa/carbidopa is not efficient reducing nausea.

The first approved product by the FDA containing only carbidopa was developed by Amerigens Pharmaceuticals Ltd and approved on 2014.

Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements.

Carbidopa is a type of Nervous System Agents


Nervous System Agents are a crucial subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that target the intricate workings of the nervous system. These agents play a pivotal role in managing various neurological conditions and disorders by modulating the neurotransmitters and receptors involved in nerve signaling.

Nervous System Agents encompass a wide range of pharmaceutical APIs, including but not limited to antiepileptic drugs, antidepressants, antipsychotics, anxiolytics, and analgesics. These APIs work by interacting with specific molecular targets in the nervous system, such as neurotransmitter receptors or enzymes involved in neurotransmitter synthesis or degradation.

One notable class of Nervous System Agents is CGRP (Calcitonin Gene-Related Peptide) antagonists. CGRP is a neuropeptide involved in the transmission of pain signals in the central and peripheral nervous systems. CGRP antagonists act by blocking the CGRP receptors, thereby inhibiting the CGRP-mediated pain pathway.

CGRP antagonists have shown promising therapeutic potential in the management of migraine headaches. By selectively targeting CGRP receptors, these pharmaceutical APIs can effectively prevent or reduce the frequency and severity of migraines. They offer an alternative treatment option for patients who do not respond well to conventional migraine medications.

The development and utilization of Nervous System Agents, including CGRP antagonists, represent a significant advancement in the field of neuropharmacology. These APIs provide healthcare professionals with valuable tools to address various neurological disorders, ultimately improving patients' quality of life. Continued research and innovation in this subcategory are expected to lead to further breakthroughs in the treatment of nervous system-related conditions.


Carbidopa (Nervous System Agents), classified under Central Nervous System Agents


Central Nervous System (CNS) Agents are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that specifically target the central nervous system. The CNS encompasses the brain and spinal cord, playing a vital role in regulating and controlling various bodily functions, including cognition, movement, emotions, and sensory perception. These agents are designed to interact with specific receptors, enzymes, or ion channels within the CNS to modulate neural activity and restore normal functioning.

CNS agents comprise a diverse range of pharmaceutical APIs, including analgesics, anesthetics, antipsychotics, sedatives, hypnotics, anti-epileptics, and antidepressants. Each subcategory addresses distinct neurological disorders and conditions. For instance, analgesics alleviate pain by targeting receptors in the brain and spinal cord, while antipsychotics are employed to manage psychosis symptoms in mental illnesses such as schizophrenia.

The development of CNS agents involves rigorous research, molecular modeling, and extensive clinical trials to ensure safety, efficacy, and specific target engagement. Pharmaceutical companies invest significant resources in identifying novel drug targets, synthesizing new compounds, and optimizing their pharmacological properties. These agents undergo rigorous regulatory evaluations and must adhere to stringent quality standards and guidelines.

Given the prevalence of CNS disorders globally, the market demand for effective CNS agents is substantial. The development of innovative CNS APIs not only improves patient outcomes but also provides valuable commercial opportunities for pharmaceutical companies. Continued advancements in CNS agent research and development hold the promise of groundbreaking therapies that can improve the quality of life for individuals affected by neurological conditions.



Carbidopa manufacturers | traders | suppliers

We have 11 companies offering Carbidopa produced in 5 different countries.

Get in contact with the supplier of your choice:

  • Sinoway industrial Co.,Ltd from China, product country of origin China
  • Duchefa Farma B.V. from Netherlands, product country of origin India
  • TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
  • Teva API from Israel, product country of origin Unknown
  • Zhejiang Chiral M.C. from China, product country of origin China
  • Zhejiang Wild Wind from China, product country of origin China
  • Glochem from India, product country of origin India
  • Shandong Xinhua from China, product country of origin China
  • Divis Labs. from India, product country of origin India
  • Sicor from Italy, product country of origin Italy
  • Fermion from Finland, product country of origin Finland

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.